Filaggrin in atopic dermatitis: Flaky tail mice as a novel model for developing drug targets in atopic dermatitis

Inflammation and Allergy - Drug Targets

Volumn 10, Issue 6, 2011, Pages 477-485

  Moniaga, Catharina Sagita ^a   Kabashima, Kenji ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atopic dermatitis; Filaggrin; Flaky tail mice; Skin barrier

Indexed keywords

FILAGGRIN; HOUSE DUST ALLERGEN;

ARTICLE; ATOPIC DERMATITIS; FLAKY TAIL MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH17 CELL;

EID: 81155126237     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152811798104881     Document Type: Article

References (89)

1. Bieber, T. Atopic dermatitis. N. Engl. J. Med., 2008, 358(14), 1483-1494.
2. Tokura, Y. Extrinsic and intrinsic types of atopic dermatitis. J. Dermatol. Sci., 2010, 58(1), 1-7.
3. Mori, T.; Ishida, K.; Mukumoto, S.; Yamada, Y.; Imokawa, G.; Kabashima, K.; Kobayashi, M.; Bito, T.; Nakamura, M.; Ogasawara, K.; Tokura, Y. Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE-high extrinsic and IgE-normal intrinsic types of atopic dermatitis. Br. J. Dermatol., 2010, 162(1), 83-90.
4. Jin, H.; He, R.; Oyoshi, M.; Geha, R. S. Animal models of atopic dermatitis. J. Invest. Dermatol., 2009, 129(1), 31-40.
5. Shiohara, T.; Hayakawa, J.; Mizukawa, Y. Animal models for atopic dermatitis: are they relevant to human disease? J. Dermatol. Sci., 2004, 36(1), 1-9.
6. Matsuda, H.; Watanabe, N.; Geba, G. P.; Sperl, J.; Tsudzuki, M.; Hiroi, J.; Matsumoto, M.; Ushio, H.; Saito, S.; Askenase, P. W.; Ra, C. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol., 1997, 9(3), 461-466.
7. Scharschmidt, T. C.; Segre, J. A. Modeling atopic dermatitis with increasingly complex mouse models. J. Invest. Dermatol., 2008, 128(5), 1061-1064.
8. Osawa, R.; Akiyama, M.; Shimizu, H. Filaggrin gene defects and the risk of developing allergic disorders. Allergol. Int., 2011, 60(1), 1-9.
9. Akiyama, M.; Shimizu, H. An update on molecular aspects of the non-syndromic ichthyoses. Exp. Dermatol., 2008, 17(5), 373-382.
10. O'Regan, G. M.; Irvine, A. D. The role of filaggrin in the atopic diathesis. Clin. Exp. Allergy, 2010, 40(7), 965-972.
11. Schleimer, R. P.; Kato, A.; Kern, R.; Kuperman, D.; Avila, P. C. Epithelium: at the interface of innate and adaptive immune responses. J. Allergy Clin. Immunol., 2007, 120(6), 1279-1284.
12. Leung, D. Y.; Bieber, T. Atopic dermatitis. Lancet, 2003, 361(9352), 151-160.
13. Aioi, A.; Tonogaito, H.; Suto, H.; Hamada, K.; Ra, C. R.; Ogawa, H.; Maibach, H.; Matsuda, H. Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis. Br. J. Dermatol., 2001, 144(1), 12-18.
14. Cork, M. J.; Danby, S. G.; Vasilopoulos, Y.; Hadgraft, J.; Lane, M. E.; Moustafa, M.; Guy, R. H.; Macgowan, A. L.; Tazi-Ahnini, R.; Ward, S. J. Epidermal barrier dysfunction in atopic dermatitis. J. Invest.Dermatol., 2009, 129(8), 1892-1908.
15. Elias, P. M.; Hatano, Y.; Williams, M. L. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J. Allergy. Clin. Immunol., 2008, 121(6), 1337-1343.
16. Irvine, A. D.; McLean, W. H. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J. Invest. Dermatol., 2006, 126(6), 1200-1202.
17. Brown, S. J.; Sandilands, A.; Zhao, Y.; Liao, H.; Relton, C. L.; Meggitt, S. J.; Trembath, R. C.; Barker, J. N.; Reynolds, N. J.; Cordell, H. J.; McLean, W. H. Prevalent and low-frequency null mutations in the filaggrin gene are associated with early-onset and persistent atopic eczema. J. Invest. Dermatol., 2008, 128(6), 1591-1594.
18. Candi, E.; Schmidt, R.; Melino, G. The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol., 2005, 6(4), 328-340.
19. Listwan, P.; Rothnagel, J. A. Keratin bundling proteins. Methods Cell Biol., 2004, 78, 817-827.
20. Nachat, R.; Mechin, M. C.; Takahara, H.; Chavanas, S.; Charveron, M.; Serre, G.; Simon, M. Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin. J. Invest. Dermatol., 2005, 124(2), 384-393.
21. Rawlings, A. V.; Harding, C. R. Moisturization and skin barrier function. Dermatol. Ther., 2004, 17(Suppl 1), 43-48.
22. Gan, S. Q.; McBride, O. W.; Idler, W. W.; Markova, N.; Steinert, P. M. Organization, structure, and polymorphisms of the human profilaggrin gene. Biochemistry, 1990, 29(40), 9432-9440.
23. Sandilands, A.; Terron-Kwiatkowski, A.; Hull, P. R.; O'Regan, G. M.; Clayton, T. H.; Watson, R. M.; Carrick, T.; Evans, A. T.; Liao, H.; Zhao, Y.; Campbell, L. E.; Schmuth, M.; Gruber, R.; Janecke, A. R.; Elias, P. M.; van Steensel, M. A.; Nagtzaam, I.; van Geel, M.; Steijlen, P. M.; Munro, C. S.; Bradley, D. G.; Palmer, C. N.; Smith, F. J.; McLean, W. H.; Irvine, A. D. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat. Genet., 2007, 39(5), 650-654.
24. Nemoto-Hasebe, I.; Akiyama, M.; Nomura, T.; Sandilands, A.; McLean, W. H.; Shimizu, H. FLG mutation p.Lys4021X in the C-terminal imperfect filaggrin repeat in Japanese patients with atopic eczema. Br. J. Dermatol., 2009, 161(6), 1387-1390.
25. Pearton, D. J.; Nirunsuksiri, W.; Rehemtulla, A.; Lewis, S. P.; Presland, R. B.; Dale, B. A. Proprotein convertase expression and localization in epidermis: evidence for multiple roles and substrates. Exp. Dermatol., 2001, 10(3), 193-203.
26. Leyvraz, C.; Charles, R. P.; Rubera, I.; Guitard, M.; Rotman, S.; Breiden, B.; Sandhoff, K.; Hummler, E. The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J. Cell Biol., 2005, 170(3), 487-496.
27. Matsui, T.; Miyamoto, K.; Kubo, A.; Kawasaki, H.; Ebihara, T.; Hata, K.; Tanahashi, S.; Ichinose, S.; Imoto, I.; Inazawa, J.; Kudoh, J.; Amagai, M. SASPase regulates stratum corneum hydration through profilaggrin-to-filaggrin processing. EMBO Mol. Med., 2011, 3(6), 320-333.
28. Hoste, E.; Kemperman, P.; Devos, M.; Denecker, G.; Kezic, S.; Yau, N.; Gilbert, B.; Lippens, S.; De Groote, P.; Roelandt, R.; Van Damme, P.; Gevaert, K.; Presland, R. B.; Takahara, H.; Puppels, G.; Caspers, P.; Vandenabeele, P.; Declercq, W. Caspase-14 Is Required for Filaggrin Degradation to Natural Moisturizing Factors in the Skin. J. Invest. Dermatol., 2011, [E-pub ahead of print].
29. Palmer, C. N.; Irvine, A. D.; Terron-Kwiatkowski, A.; Zhao, Y.; Liao, H.; Lee, S. P.; Goudie, D. R.; Sandilands, A.; Campbell, L. E.; Smith, F. J.; O'Regan, G. M.; Watson, R. M.; Cecil, J. E.; Bale, S. J.; Compton, J. G.; DiGiovanna, J. J.; Fleckman, P.; Lewis-Jones, S.; Arseculeratne, G.; Sergeant, A.; Munro, C. S.; El Houate, B.; McElreavey, K.; Halkjaer, L. B.; Bisgaard, H.; Mukhopadhyay, S.; McLean, W. H. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet., 2006, 38(4), 441-446.
30. Marenholz, I.; Nickel, R.; Ruschendorf, F.; Schulz, F.; Esparza-Gordillo, J.; Kerscher, T.; Gruber, C.; Lau, S.; Worm, M.; Keil, T.; Kurek, M.; Zaluga, E.; Wahn, U.; Lee, Y. A. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J. Allergy Clin. Immunol., 2006, 118(4), 866-871.
31. Sandilands, A.; O'Regan, G. M.; Liao, H.; Zhao, Y.; Terron-Kwiatkowski, A.; Watson, R. M.; Cassidy, A. J.; Goudie, D. R.; Smith, F. J.; McLean, W. H.; Irvine, A. D. Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J. Invest. Dermatol., 2006, 126(8), 1770-1775.
32. Brown, S. J.; Relton, C. L.; Liao, H.; Zhao, Y.; Sandilands, A.; Wilson, I. J.; Burn, J.; Reynolds, N. J.; McLean, W. H.; Cordell, H. J. Filaggrin null mutations and childhood atopic eczema: a population-based case-control study. J. Allergy Clin. Immunol., 2008, 121(4), 940-946 e3.
33. Nomura, T.; Sandilands, A.; Akiyama, M.; Liao, H.; Evans, A. T.; Sakai, K.; Ota, M.; Sugiura, H.; Yamamoto, K.; Sato, H.; Palmer, C. N.; Smith, F. J.; McLean, W. H.; Shimizu, H. Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J. Allergy Clin. Immunol., 2007, 119(2), 434-440.
34. Rodriguez, E.; Baurecht, H.; Herberich, E.; Wagenpfeil, S.; Brown, S. J.; Cordell, H. J.; Irvine, A. D.; Weidinger, S. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J. Allergy Clin. Immunol., 2009, 123(6), 1361-1370 e7.
35. Illi, S.; von Mutius, E.; Lau, S.; Nickel, R.; Gruber, C.; Niggemann, B.; Wahn, U. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J. Allergy Clin. Immunol., 2004, 113(5), 925-931.
36. Muller, S.; Marenholz, I.; Lee, Y. A.; Sengler, C.; Zitnik, S. E.; Griffioen, R. W.; Meglio, P.; Wahn, U.; Nickel, R. Association of Filaggrin loss-of-function-mutations with atopic dermatitis and asthma in the Early Treatment of the Atopic Child (ETAC) population. Pediatr. Allergy Immunol., 2009, 20(4), 358-361.
37. Brown, S. J.; Asai, Y.; Cordell, H. J.; Campbell, L. E.; Zhao, Y.; Liao, H.; Northstone, K.; Henderson, J.; Alizadehfar, R.; Ben-Shoshan, M.; Morgan, K.; Roberts, G.; Masthoff, L. J.; Pasmans, S. G.; van den Akker, P. C.; Wijmenga, C.; Hourihane, J. O.; Palmer, C. N.; Lack, G.; Clarke, A.; Hull, P. R.; Irvine, A. D.; McLean, W. H. Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J. Allergy Clin. Immunol., 2011, 127(3), 661-667.
38. Poninska, J.; Samolinski, B.; Tomaszewska, A.; Raciborski, F.; Samel-Kowalik, P.; Walkiewicz, A.; Lipiec, A.; Piekarska, B.; Komorowski, J.; Krzych-Falta, E.; Namyslowski, A.; Borowicz, J.; Kostrzewa, G.; Majewski, S.; Ploski, R. Filaggrin gene defects are independent risk factors for atopic asthma in a Polish population: a study in ECAP cohort. PLoS One, 2011, 6(2), e16933.
39. Novak, N.; Baurecht, H.; Schafer, T.; Rodriguez, E.; Wagenpfeil, S.; Klopp, N.; Heinrich, J.; Behrendt, H.; Ring, J.; Wichmann, E.; Illig, T.; Weidinger, S. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J. Invest. Dermatol., 2008, 128(6), 1430-1435.
40. Kezic, S.; Kemperman, P. M.; Koster, E. S.; de Jongh, C. M.; Thio, H. B.; Campbell, L. E.; Irvine, A. D.; McLean, W. H.; Puppels, G. J.; Caspers, P. J. Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J. Invest. Dermatol., 2008, 128(8), 2117-2119.
41. Sergeant, A.; Campbell, L. E.; Hull, P. R.; Porter, M.; Palmer, C. N.; Smith, F. J.; McLean, W. H.; Munro, C. S. Heterozygous null alleles in filaggrin contribute to clinical dry skin in young adults and the elderly. J. Invest. Dermatol., 2009, 129(4), 1042-1045.
42. Nemoto-Hasebe, I.; Akiyama, M.; Nomura, T.; Sandilands, A.; McLean, W. H.; Shimizu, H. Clinical severity correlates with impaired barrier in filaggrin-related eczema. J. Invest. Dermatol., 2009, 129(3), 682-689.
43. Weidinger, S.; O'Sullivan, M.; Illig, T.; Baurecht, H.; Depner, M.; Rodriguez, E.; Ruether, A.; Klopp, N.; Vogelberg, C.; Weiland, S. K.; McLean, W. H.; von Mutius, E.; Irvine, A. D.; Kabesch, M. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J. Allergy Clin. Immunol., 2008, 121(5), 1203-1209 e1.
44. Wang, I. J.; Lin, T. J.; Kuo, C. F.; Lin, S. L.; Lee, Y. L.; Chen, P. C. Filaggrin polymorphism P478S, IgE level, and atopic phenotypes. Br. J. Dermatol., 2011, 164(4), 791-796.
45. Hubiche, T.; Ged, C.; Benard, A.; Leaute-Labreze, C.; McElreavey, K.; de Verneuil, H.; Taieb, A.; Boralevi, F. Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort. Acta Derm. Venereol., 2007, 87(6), 499-505.
46. Carlsen, B. C.; Thyssen, J. P.; Menne, T.; Meldgaard, M.; Linneberg, A.; Nielsen, N. H.; Szecsi, P. B.; Stender, S.; Johansen, J. D. Association between filaggrin null mutations and concomitant atopic dermatitis and contact allergy. Clin. Exp. Dermatol., 2011. [E-pub ahead of print]
47. O'Regan, G. M.; Campbell, L. E.; Cordell, H. J.; Irvine, A. D.; McLean, W. H.; Brown, S. J. Chromosome 11q13.5 variant associated with childhood eczema: an effect supplementary to filaggrin mutations. J. Allergy Clin. Immunol., 2010, 125(1), 170-4 e1-2.
48. Wollenberg, A.; Bieber, T. Atopic dermatitis: from the genes to skin lesions. Allergy, 2000, 55(3), 205-213.
49. Jakasa, I.; Koster, E. S.; Calkoen, F.; McLean, W. H.; Campbell, L. E.; Bos, J. D.; Verberk, M. M.; Kezic, S. Skin barrier function in healthy subjects and patients with atopic dermatitis in rela tion to filaggrin loss-of-function mutations. J. Invest. Dermatol., 2011, 131(2), 540-542.
50. Onoue, A.; Kabashima, K.; Kobayashi, M.; Mori, T.; Tokura, Y. Induction of eosinophil- and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin. Exp. Dermatol., 2009, 18(12), 1036-1043.
51. Jungersted, J. M.; Scheer, H.; Mempel, M.; Baurecht, H.; Cifuentes, L.; Hogh, J. K.; Hellgren, L. I.; Jemec, G. B.; Agner, T.; Weidinger, S. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy, 2010, 65(7), 911-8.
52. Angelova-Fischer, I.; Mannheimer, A. C.; Hinder, A.; Ruether, A.; Franke, A.; Neubert, R. H.; Fischer, T. W.; Zillikens, D. Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling. Exp. Dermatol., 2011, 20(4), 351-356.
53. Jokura, Y.; Ishikawa, S.; Tokuda, H.; Imokawa, G. Molecular analysis of elastic properties of the stratum corneum by solid-state 13C-nuclear magnetic resonance spectroscopy. J. Invest. Dermatol., 1995, 104(5), 806-812.
54. Kezic, S.; Kammeyer, A.; Calkoen, F.; Fluhr, J. W.; Bos, J. D. Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methods. Br. J. Dermatol., 2009, 161(5), 1098-1104.
55. Mildner, M.; Jin, J.; Eckhart, L.; Kezic, S.; Gruber, F.; Barresi, C.; Stremnitzer, C.; Buchberger, M.; Mlitz, V.; Ballaun, C.; Sterniczky, B.; Fodinger, D.; Tschachler, E. Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model. J. Invest. Dermatol., 2010, 130(9), 2286-2294.
56. Vroling, A. B.; Fokkens, W. J.; van Drunen, C. M. How epithelial cells detect danger: aiding the immune response. Allergy, 2008, 63(9), 1110-1123.
57. Ebner, S.; Nguyen, V. A.; Forstner, M.; Wang, Y. H.; Wolfram, D.; Liu, Y. J.; Romani, N. Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. J. Allergy Clin. Immunol., 2007, 119(4), 982-990.
58. Ziegler, S. F. The role of thymic stromal lymphopoietin (TSLP) in allergic disorders. Curr. Opin. Immunol., 2010, 22(6), 795-799.
59. Soumelis, V.; Reche, P. A.; Kanzler, H.; Yuan, W.; Edward, G.; Homey, B.; Gilliet, M.; Ho, S.; Antonenko, S.; Lauerma, A.; Smith, K.; Gorman, D.; Zurawski, S.; Abrams, J.; Menon, S.; McClanahan, T.; de Waal-Malefyt R.; Bazan, F.; Kastelein, R. A.; Liu, Y. J. Human epithelial cells trigger dendritic cell mediated allergic inf lammation by producing TSLP. Nat. Immunol., 2002, 3(7), 673-680.
60. Yoo, J.; Omori, M.; Gyarmati, D.; Zhou, B.; Aye, T.; Brewer, A.; Comeau, M. R.; Campbell, D. J.; Ziegler, S. F. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J. Exp. Med., 2005, 202(4), 541-9.
61. Lee, K. H.; Cho, K. A.; Kim, J. Y.; Baek, J. H.; Woo, S. Y.; Kim, J. W. Filaggrin knockdown and Toll-like receptor 3 (TLR3) stimulation enhanced the production of thymic stromal lymphopoietin (TSLP) from epidermal layers. Exp. Dermatol., 2011, 20(2), 149-151.
62. Lane, P. W. Two new mutations in linkage group XVI of the house mouse. Flaky tail and varitint-waddler-J. J. Hered, 1972, 63(3), 135-140.
63. Presland, R. B.; Boggess, D.; Lewis, S. P.; Hull, C.; Fleckman, P.; Sundberg, J. P. Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J. Invest. Dermatol., 2000, 115(6), 1072-1081.
64. Fallon, P. G.; Sasaki, T.; Sandilands, A.; Campbell, L. E.; Saunders, S. P.; Mangan, N. E.; Callanan, J. J.; Kawasaki, H.; Shiohama, A.; Kubo, A.; Sundberg, J. P.; Presland, R. B.; Fleckman, P.; Shimizu, N.; Kudoh, J.; Irvine, A. D.; Amagai, M.; McLean, W. H. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat. Genet., 2009, 41(5), 602-608.
65. Jarret A. The keratin defect and hair-cycle of a new mutant (atted) in the house-mouse. J. Embryol. exp. Morph., 1957, 5, 103-110.
66. Searle A.G. Matted, a new hair-mutant in the house-mouse: Genetics and morphology. J. Embryol. exp. Morph., 1957, 5, 93-102.
67. Scharschmidt, T. C.; Man, M. Q.; Hatano, Y.; Crumrine, D.; Gunathilake, R.; Sundberg, J. P.; Silva, K. A.; Mauro, T. M.; Hupe, M.; Cho, S.; Wu, Y.; Celli, A.; Schmuth, M.; Feingold, K. R.; Elias, P. M. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J. Allergy Clin. Immunol., 2009, 124(3), 496-506, 506 e1-6.
68. Moniaga, C. S.; Egawa, G.; Kawasaki, H.; Hara-Chikuma, M.; Honda, T.; Tanizaki, H.; Nakajima, S.; Otsuka, A.; Matsuoka, H.; Kubo, A.; Sakabe, J.; Tokura, Y.; Miyachi, Y.; Amagai, M.; Kabashima, K. Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract. Am. J. Pathol., 2010, 176(5), 2385-2393.
69. Oyoshi, M. K.; Murphy, G. F.; Geha, R. S. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J, Allergy Clin, Immunol, 2009, 124(3), 485-93, 493 e1.
70. Novak, N. New insights into the mechanism and management of allergic diseases: atopic dermatitis. Allergy, 2009, 64(2), 265-275.
71. Farage, M. A.; Katsarou, A.; Maibach, H. I. Sensory, clinical and physiological factors in sensitive skin: a review. Contact Dermatitis, 2006, 55(1), 1-14.
72. Willis, C. M.; Shaw, S.; De Lacharriere, O.; Baverel, M.; Reiche, L.; Jourdain, R.; Bastien, P.; Wilkinson, J. D. Sensitive skin: an epidemiological study. Br. J. Dermatol., 2001, 145(2), 258-263.
73. Clayton, T. H.; Wilkinson, S. M.; Rawcliffe, C.; Pollock, B.; Clark, S. M. Allergic contact dermatitis in children: should pattern of dermatitis determine referral? A retrospective study of 500 children tested between 1995 and 2004 in one U.K. centre. Br. J. Dermatol., 2006, 154(1), 114-117.
74. Mailhol, C.; Lauwers-Cances, V.; Rance, F.; Paul, C.; Giordano-Labadie, F. Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children. Allergy, 2009, 64(5), 801-806.
75. Gruber, C.; Kulig, M.; Bergmann, R.; Guggenmoos-Holzmann, I.; Wahn, U. Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization, and atopic manifestation in longitudinally followed early Bacille Calmette-Guerin-vaccinated and nonvaccinated children. Pediatrics, 2001, 107(3), E36.
76. Yilmaz, M.; Bingol, G.; Altintas, D.; Kendirli, S. G. Correlation between atopic diseases and tuberculin responses. Allergy, 2000, 55(7), 664-667.
77. Wang, B.; Feliciani, C.; Freed, I.; Cai, Q.; Sauder, D. N. Insights into molecular mechanisms of contact hypersensitivity gained from gene knockout studies. J. Leukoc. Biol., 2001, 70(2), 185-191.
78. Mori, T.; Kabashima, K.; Yoshiki, R.; Sugita, K.; Shiraishi, N.; Onoue, A.; Kuroda, E.; Kobayashi, M.; Yamashita, U.; Tokura, Y. Cutaneous hypersensitivities to hapten are controlled by IFN-gamma-upregulated keratinocyte Th1 chemokines and IFN-gamma-downregulated langerhans cell Th2 chemokines. J. Invest. Dermatol., 2008, 128(7), 1719-1727.
79. Honda, T.; Miyachi, Y.; Kabashima, K. The role of regulatory T cells in contact hypersensitivity. Recent Pat. Inflamm. Allergy Drug Discov., 2010, 4(2), 85-89.
80. Kimura, M.; Tsuruta, S.; Yoshida, T. Correlation of house dust mite-specific lymphocyte proliferation with IL-5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitis. J. Allergy Clin. Immunol., 1998, 101(1 Pt 1), 84-89.
81. Henderson, J.; Northstone, K.; Lee, S. P.; Liao, H.; Zhao, Y.; Pembrey, M.; Mukhopadhyay, S.; Smith, G. D.; Palmer, C. N.; McLean, W. H.; Irvine, A. D. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J. Allergy Clin. Immunol., 2008, 121(4), 872-877 e9.
82. Vasilopoulos, Y.; Cork, M. J.; Teare, D.; Marinou, I.; Ward, S. J.; Duff, G. W.; Tazi-Ahnini, R. A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis. Allergy, 2007, 62(5), 514-519.
83. Jeong, S. K.; Kim, H. J.; Youm, J. K.; Ahn, S. K.; Choi, E. H.; Sohn, M. H.; Kim, K. E.; Hong, J. H.; Shin, D. M.; Lee, S. H. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J. Invest. Dermatol., 2008, 128(8), 1930-1939.
84. Roelandt, T.; Heughebaert, C.; Hachem, J. P. Proteolytically active allergens cause barrier breakdown. J. Invest. Dermatol., 2008, 128(8), 1878-1880.
85. Kang, J. S.; Lee, K.; Han, S. B.; Ahn, J. M.; Lee, H.; Han, M. H.; Yoon, Y. D.; Yoon, W. K.; Park, S. K.; Kim, H. M. Induction of atopic eczema/dermatitis syndrome-like skin lesions by repeated topical application of a crude extract of Dermatophagoides pteronyssinus in NC/Nga mice. Int. Immunopharmacol., 2006, 6(10), 1616-1622.
86. Yamamoto, M.; Haruna, T.; Yasui, K.; Takahashi, H.; Iduhara, M.; Takaki, S.; Deguchi, M.; Arimura, A. A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. Allergol. Int., 2007, 56(2), 139-148.
87. Elias, P. M. Therapeutic Implications of a Barrier-based Pathogenesis of Atopic Dermatitis. Ann. Dermatol., 2010, 22(3), 245-254.
88. Lequeux, C.; Lhoste, A.; Rovere, M. R.; Montastier, C.; Damour, O. Model of in vitro healing to test the influence of dedifferentiated Crithmum maritimum cells on dermal repair and epidermal regeneration. Skin Pharmacol. Physiol., 2011, 24(2), 75-80.
89. Jin, G.; Prabhakaran, M. P.; Ramakrishna, S. Stem cell differentiation to epidermal lineages on electrospun nanofibrous substrates for skin tissue engineering. Acta Biomater, 2011. [E-pub ahead of print].